Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10130417 | 0.96 | ALOX5 (0.33) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL10130415 | 0.90 | ALOX5 (0.33) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL10130405 | 0.88 | PLA2G2A (0.39) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL10130456 | 0.86 | PLA2G2A (0.38) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL18996163 | 0.86 | PLA2G2A (0.38) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL9949773 | 0.86 | PLA2G2A (0.40) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL10130442 | 0.86 | PLA2G2A (0.40) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL29406326 | 0.86 | PLA2G2A (0.40) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL10443238 | 0.86 | ALOX5 (0.46) | ALOX5PLA2G2APLA2G4APLA2G10CDC14B | |
| SCHEMBL18267031 | 0.85 | GPR84 (0.33) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120165556-A1 | Benzo[b]Naphtho[1,2-d]Furan Compound as Light-Emitting Element Material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-06-28 | — | — | US | disclosed |
| US-20120165556-A1 | Benzo[b]Naphtho[1,2-d]Furan Compound as Light-Emitting Element Material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165556-A1 | Benzo[b]Naphtho[1,2-d]Furan Compound as Light-Emitting Element Material | CYP1B1, CTNND1, CTNNB1 | ALOX5 1628/4885PLA2G2A 1889/4885PLA2G4A 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.